AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Company initiates intranasal parathyroid hormone clinical development.

Women's Health Weekly

| June 03, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUN 3 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Co., Inc., (NSTK) has commenced a phase I clinical trial to evaluate intranasal administration of human parathyroid hormone 1-34 (PTH1-34) in healthy subjects.

"We are pleased to have added PTH1-34 to a list of nasal dosage forms of large-molecule peptides and proteins that Nastech has tested in humans," stated Steven C. Quay, MD, PhD, chairman, president, and chief executive officer. "PTH1-34 Nasal Spray, for which we have filed patent applications, represents an important opportunity to expand our portfolio of intranasal dosage forms based on our proprietary Tight Junction drug-delivery technology. The potential global market for a nasal spray dosage form of PTH1-34 is significant."

PTH1-34 is a fragment of the naturally occurring human parathyroid hormone that is an important regulator of calcium and phosphorus metabolism. When given by daily injection, PTH1-34 has been shown to increase bone mineral density (BMD) and significantly ...

Related articles from newspapers, magazines, journals, and more
Parathyroid hormone gene therapy may stop osteoporosis in postmenopausal women.
Magazine article from: Women's Health Weekly January 22, 2004 700+ words
...length human parathyroid hormone (prepro-hPTH...gene transfer of parathyroid hormone might be a promising...gene transfer of parathyroid hormone. Biotechnol Lett...prepared by Women's Health Weekly editors from staff...
Intermittent parathyroid hormone stimulates bone growth in postmenopausal women.
Magazine article from: Women's Health Weekly March 18, 2004 700+ words
...fragment of human parathyroid hormone, is a bone formation...Intermittent parathyroid hormone administration...teriparatide (Parathyroid hormone) in patients with...prepared by Women's Health Weekly editors from staff...
New research explains why only intermittent parathyroid hormone grows new bone.
Magazine article from: Women's Health Weekly February 5, 2004 700+ words
...only intermittent parathyroid hormone grows new bone...sustained elevation of parathyroid hormone (PTH) stimulates...Runx2 shortens parathyroid hormone-induced anti...prepared by Women's Health Weekly editors from staff...
Bone resorption inhibitors impact the anabolic effect of parathyroid hormone.
Magazine article from: Women's Health Weekly May 20, 2004 700+ words
...anabolic effect of parathyroid hormone. According to...from the use of parathyroid hormone (PTH) as an anabolic...anabolic response to parathyroid hormone? Trends Endocrinol...prepared by Women's Health Weekly editors from staff...
Parathyroid hormone production diverges with surgical versus natural menopause.
Magazine article from: Women's Health Weekly April 1, 2004 700+ words
...NewsRx.net) -- Parathyroid hormone production diverges...included hormones [parathyroid hormone (PTH) and the...prepared by Women's Health Weekly editors from staff...2004, Women's Health Weekly via NewsRx.com...
Low vitamin D and high parathyroid hormone cause sarcopenia in older people.
Magazine article from: Women's Health Weekly February 5, 2004 700+ words
...vitamin D and high parathyroid hormone cause sarcopenia...vitamin D and high parathyroid hormone levels as determinants...prepared by Women's Health Weekly editors from staff...2004, Women's Health Weekly via NewsRx.com...
Parathyroid hormone may mediate pre-existing osteoporosis during pregnancy.
Magazine article from: Women's Health Weekly February 27, 2003 700+ words
...9, and 30.0 U/liter, respectively)." "Parathyroid hormone (PTH) was measured by two methods to assess the...Endocrinology. This article was prepared by Women's Health Weekly editors from staff and other reports.
Phase I human study initiated for parathyroid hormone osteoporosis product.
Magazine article from: Women's Health Weekly July 22, 2004 700+ words
...for an oral formulation of parathyroid hormone (PTH) osteoporosis product...article was prepared by Women's Health Weekly editors from staff and other...Copyright 2004, Women's Health Weekly via NewsRx.com & NewsRx...
For more facts and information, see all results

Source: HighBeam Research, Company initiates intranasal parathyroid hormone clinical development.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA